Culley Brian M Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
8
Insider Buys Sum
$91,334.00
Insider Sells Quantity
2
Insider Sells Sum
$1.3M

Insider Activity of Culley Brian M

According to the SEC Form 4 filings, Culley Brian M, being in a position of

  1. President and CEO at Lineage Cell Therapeutics, Inc.,
    оver the last 12 months, has bought 15000 shares for $24,375, and sold 0 shares,
    over all time since 2019-08-13, has bought 86650 shares for $86,012, and sold 450000 shares for $1.29M.

Biography of Culley Brian M

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $24,3751100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-03-12PurchaseLineage Cell Therapeutics, Inc.
LCTX
President and CEO
15,000
0.0067%
$1.63$24,375-24.05%
2024-11-21PurchaseLineage Cell Therapeutics, Inc.
LCTX
President and CEO
40,000
0.0213%
$0.60$24,000+14.63%
2024-05-24PurchaseLineage Cell Therapeutics, Inc.
LCTX
President and CEO
10,000
0.0054%
$1.05$10,500-31.53%
2022-03-31PurchaseLineage Cell Therapeutics, Inc.
LCTX
President and CEO
6,400
0.0037%
$1.53$9,792-11.04%
2022-03-25PurchaseLineage Cell Therapeutics, Inc.
LCTX
President and CEO
5,250
0.0029%
$1.38$7,245-7.43%
2021-06-28SaleLineage Cell Therapeutics, Inc.
LCTX
President and CEO
450,000
0.2743%
$2.87$1.29M-28.72%
2019-08-13PurchaseLineage Cell Therapeutics, Inc.
LCTX
President and CEO
10,000
0.0066%
$1.01$10,100-4.78%
2012-03-14PurchaseSavara Inc.
SVRA
CEO and Director
20,500
0.043%
$0.59$12,103
2012-03-13PurchaseSavara Inc.
SVRA
CEO and Director
14,000
0.0294%
$0.58$8,144
2011-06-02SaleSavara Inc.
SVRA
Chief Executive Officer
5,000
0.019%
$2.44$12,200
2010-05-27PurchaseSavara Inc.
SVRA
Chief Executive Officer
5,000
0.0425%
$1.89$9,450
Total: 11
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.